Huntingtons sykdom
Sist oppdatert: Sist revidert:
Sist revidert av:Unn Ljøstad
- Caron NS, Wright GEB, Hayden MR. Huntington Disease . GeneReviews . pmid:20301482 PubMed
- McColgan P1, Tabrizi SJ1,2.. Huntington's disease: a clinical review. 2017. pmid:28817209 PubMed
- Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Huntington's disease: diagnosis and management. Pract Neurol. 2021 Aug 19:practneurol-2021-003074. doi: 10.1136/practneurol-2021-003074. Epub ahead of print. PMID: 34413240. PubMed
- Furby H, Moore S, Nordstroem AL, Houghton R, Lambrelli D, Graham S, Svenningsson P, Petersén Å. Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington's disease: a study of linked Swedish National Registries (2002-2019). J Neurol. 2022 Oct 18. doi: 10.1007/s00415-022-11418-y. Epub ahead of print. PMID: 36253622. PubMed
- Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, Hjermind LE, Lahiri N, Mandich P, Martinez A, Tibben A, Roos RA; Working Group on Genetic Counselling and Testing of the European Huntington's Disease Network (EHDN). Diagnostic genetic testing for Huntington's disease. Pract Neurol 2015; 15: 80-4. pmid:25169240 PubMed
- Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias. Eur J Neurol 2009;16(7):777-85 PMID: 20500522 PubMed
- Estevez-Fraga C, Scahill R, Rees G, Tabrizi SJ, Gregory S. Diffusion imaging in Huntington's disease: comprehensive review. J Neurol Neurosurg Psychiatry. 2020 Oct 8:jnnp-2020-324377. PMID: 33033167. PubMed
- Martino D, Stamelou M, Bhatia KP. The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician. J Neurol Neurosurg Psychiatry. 2013 ; 84: 650-6. pmid:22993450 PubMed
- Shannon KM1, Fraint A1.. Therapeutic advances in Huntington's Disease.. Mov Disord. 2015 ; Sep 15;30(11):.: 1539-46. pmid:26226924 PubMed
- Wyant KJ1, Ridder AJ2, Dayalu P2.. Huntington's Disease-Update on Treatments. Curr Neurol Neurosci Rep. 2017. pmid:28324302 PubMed
- Pan L, Feigin A. Huntington's Disease: New Frontiers in Therapeutics. Curr Neurol Neurosci Rep. 2021 Feb 14;21(3):10. doi: 10.1007/s11910-021-01093-3. PMID: 33586075. PubMed
- Armstrong MJ, Miyasaki JM;. Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012; 79: 597-603. pmid:22815556 PubMed
- Berardelli A, Suppa A.. Noninvasive brain stimulation in Huntington's disease. Handb Clin Neurol. 2013; 116: 555-60. pmid:24112923 PubMed
- Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD; Huntington Study Group CREST-E Investigators and Coordinators. The CREST-E study of creatine for Huntington disease: A randomized controlled trial.. Neurology. 2017. pmid:28701493 PubMed
- Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Therapeutic interventions for symptomatic treatment in Huntington's disease. Cochrane Database Syst Rev 2009; 8: CD006456. Cochrane (DOI)
- López-Sendón Moreno JL, García Caldentey J, Trigo Cubillo P, Ruiz Romero C, García Ribas G, Alonso Arias MA, García de Yébenes MJ, Tolón RM, Galve-Roperh I, Sagredo O, Valdeolivas S, Resel E, Ortega-Gutierrez S, García-Bermejo ML, Fernández Ruiz J, Guzmán M, García de Yébenes Prous J. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease. J Neurol. 2016 Jul;263(7):1390-400 . pmid:27159993 PubMed
- Unn Ljøstad, spesialist i nevrologi, professor PhD
- Åse Mygland, spesialist i nevrologi, professor dr med
- Elin Bjelland Forsaa, spesialist i nevrologi, PhD
- Espen Dietrichs, spesialist i nevrologi, professor dr med